Cabaletta Bio, Inc. Quarterly Operating Income (Loss) in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cabaletta Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q3 2024.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$33M, a 77% decline year-over-year.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$115M, a 68.8% decline year-over-year.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2023 was -$74.7M, a 37.9% decline from 2022.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2022 was -$54.1M, a 16.9% decline from 2021.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2021 was -$46.3M, a 36.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$115M -$33M -$14.4M -77% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$100M -$30.3M -$14.4M -90.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$85.7M -$28M -$11.1M -65.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$74.7M -$23.1M -$6.84M -42% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$67.8M -$18.7M -$6.89M -58.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$60.9M -$15.9M -$2.83M -21.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$58.1M -$17M -$3.96M -30.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$54.1M -$16.3M -$2.41M -17.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$51.7M -$11.8M -$215K -1.86% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$51.5M -$13.1M -$1.92M -17.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$49.6M -$13M -$3.29M -33.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$46.3M -$13.9M -$4.56M -48.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$41.8M -$11.6M -$3.15M -37.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$38.6M -$11.1M -$2.95M -36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$35.7M -$9.71M -$1.82M -23% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$33.8M -$9.33M -$3.47M -59.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$30.4M -$8.42M -$3.39M -67.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$27M -$8.19M -$4.39M -115% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$22.6M -$7.9M -$3.91M -97.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 -$18.7M -$5.86M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$5.03M -$1.95M -63.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$3.8M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$3.99M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 -$3.08M Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.